Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Mammary carcinogenesis is preceded by altered epithelial cell turnover in transforming growth factor-alpha and c-myc transgenic mice.

Rose-Hellekant TA, Wentworth KM, Nikolai S, Kundel DW, Sandgren EP.

Am J Pathol. 2006 Nov;169(5):1821-32.

2.

Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.

Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC.

Cancer Res. 1995 Sep 1;55(17):3915-27.

3.

Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.

Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.

Cell Growth Differ. 1995 Jun;6(6):737-48.

4.

Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.

Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, Dickson RB.

Oncogene. 1996 Aug 15;13(4):757-65.

PMID:
8761297
5.

Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).

Telang N, Katdare M.

Oncol Rep. 2011 May;25(5):1195-201. doi: 10.3892/or.2011.1215. Review.

PMID:
21399881
6.
7.
8.
9.

Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis.

Factor VM, Kiss A, Woitach JT, Wirth PJ, Thorgeirsson SS.

J Biol Chem. 1998 Jun 19;273(25):15846-53.

10.

Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice.

Sharp R, Babyatsky MW, Takagi H, T├ągerud S, Wang TC, Bockman DE, Brand SJ, Merlino G.

Development. 1995 Jan;121(1):149-61.

11.
12.

Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis.

Sgambato A, Di Salvatore MA, De Paola B, Rettino A, Faraglia B, Boninsegna A, Graziani C, Camerini A, Proietti G, Cittadini A.

J Cell Physiol. 2006 May;207(2):520-9.

PMID:
16447256
13.

Apoptosis in normal and neoplastic mammary gland development.

Strange R, Metcalfe T, Thackray L, Dang M.

Microsc Res Tech. 2001 Jan 15;52(2):171-81. Review.

PMID:
11169865
15.

Myc lacks E2F1's ability to suppress skin carcinogenesis.

Rounbehler RJ, Schneider-Broussard R, Conti CJ, Johnson DG.

Oncogene. 2001 Aug 30;20(38):5341-9.

16.

Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.

Coffey RJ Jr, Meise KS, Matsui Y, Hogan BL, Dempsey PJ, Halter SA.

Cancer Res. 1994 Apr 1;54(7):1678-83.

17.

Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.

Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, Cardiff RD, Meise KS, Li F, Halter SA, Coffey RJ.

Mol Cell Biol. 1996 Oct;16(10):5726-36.

18.

Influence of normal mammary epithelium on breast cancer progression: the protective role of early pregnancy.

Martins FC, Botelho MF, Cabrita AM, de Oliveira CF.

Tumori. 2010 Nov-Dec;96(6):999-1003.

19.
20.

Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium.

Chepko G, Slack R, Carbott D, Khan S, Steadman L, Dickson RB.

Tissue Cell. 2005 Oct;37(5):393-412.

PMID:
16137731
Items per page

Supplemental Content

Support Center